Article
Food Science & Technology
Yuanwang Wang, Dehua Wang, Houjiao Lv, Qinchen Dong, Jiajia Li, Weitao Geng, Jinju Wang, Fufeng Liu, Longgang Jia, Yanping Wang
Summary: Regulating the gut microecology with probiotics is an effective strategy for the prevention and treatment of Alzheimer's disease (AD). This study demonstrates that a functional probiotic, Lactobacillus plantarum MA2, isolated from traditional Chinese Tibetan kefir grains, can improve cognitive deficits and anxiety-like behaviors in AD rats. It also attenuates neuronal degeneration and Aβ accumulation in the brain. Furthermore, the study shows that MA2 alleviates intestinal mucosal impairments and inhibits microglia activation and neuroinflammation through the TLR4/MYD88/NLRP3 signaling pathway. The findings suggest that MA2 reshapes the gut microbiota and modulates glycometabolism, and its exopolysaccharides (EPS) have inhibitory effects on Aβ aggregation and cytotoxicity induced by amyloid.
MOLECULAR NUTRITION & FOOD RESEARCH
(2022)
Review
Cell Biology
Xiao-hang Qian, Xiao-xuan Song, Xiao-li Liu, Sheng-di Chen, Hui-dong Tang
Summary: Multiple studies in the past decade have shown the close relationship between gut microbiota and Alzheimer's disease (AD), but the specific mechanism is still unclear. Inflammation, both neuroinflammation and systemic inflammation, play a key role in accelerating the process of AD. Gut microbiota regulation of inflammation is crucial in the development of AD.
AGEING RESEARCH REVIEWS
(2021)
Article
Nutrition & Dietetics
Valentina Cecarini, Olee Gogoi, Laura Bonfili, Iolanda Veneruso, Giada Pacinelli, Sara De Carlo, Federica Benvenuti, Valeria D'Argenio, Mauro Angeletti, Nazzareno Cannella, Anna Maria Eleuteri
Summary: A yeast-enriched beer has beneficial effects on Alzheimer's disease by improving cognition, reducing protein aggregation and inflammation, increasing anti-inflammatory cytokines, improving gut bacterial population, and decreasing gut inflammatory fungi.
Article
Agriculture, Multidisciplinary
Shujian Wu, Qingping Wu, Juan Wang, Yangfu Li, Bo Chen, Zhenjun Zhu, Rui Huang, Mengfei Chen, Aohuan Huang, Yizhen Xie, Chunwei Jiao, Yu Ding
Summary: Recent studies have shown that two novel selenium peptides from Cordyceps militaris, with antioxidant, anti-inflammatory, and gut microbiota regulation properties, can pre-protect and alleviate inflammation and cognitive impairment in Alzheimer's disease.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2022)
Review
Biochemistry & Molecular Biology
Chun-Ling Dai, Fei Liu, Khalid Iqbal, Cheng-Xin Gong
Summary: The article discusses the interaction between gut microbiota, the immune system, and AD immunotherapy, emphasizing the crucial role of gut microbiota in the pathogenesis and treatment of AD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Agriculture, Multidisciplinary
Qing Liu, Tianzhi Xie, Yujia Xi, Ling Li, Fengfeng Mo, Xuebo Liu, Zhigang Liu, Jin-Ming Gao, Tian Yuan
Summary: The study showed that sesamol has significant neuroprotective effects on Alzheimer's disease (AD) mice, improving memory and learning abilities, reducing neuronal damage and protein accumulation, and acting through the microbiota-gut-brain axis.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2021)
Article
Immunology
Barbara J. H. Verhaar, Heleen M. A. Hendriksen, Francisca A. de Leeuw, Astrid S. Doorduijn, Mardou van Leeuwenstijn, Charlotte E. Teunissen, Frederik Barkhof, Philip Scheltens, Robert Kraaij, Cornelia M. van Duijn, Max Nieuwdorp, Majon Muller, Wiesje M. van der Flier
Summary: This study investigated the relationship between gut microbiota composition and AD biomarkers using machine learning models. The results showed that lower abundances of SCFA-producing microbes were associated with higher odds of positive amyloid and p-tau status. The study extends on previous findings by showing associations between gut microbiota composition and specific AD biomarkers.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Gastroenterology & Hepatology
Jinghua Jin, Zhi Xu, Lina Zhang, Can Zhang, Xiaoduo Zhao, Yuxuan Mao, Haojian Zhang, Xingguang Liang, Juanli Wu, Ying Yang, Jing Zhang
Summary: Peripheral beta-amyloid (A beta), including gut-derived A beta, is believed to contribute to the formation of A beta plaques in the brain, and the gut microbiota has an impact on Alzheimer's disease (AD) through the gut-brain axis. This study investigated the potential interactions among gut-derived A beta, gut microbiota, and AD pathogenesis. The results showed that the gut is a critical source of A beta in the brain, and gut microbiota can upregulate A beta production in the gut, potentially contributing to AD pathogenesis.
Review
Nutrition & Dietetics
Ruipu Xiu, Qingyuan Sun, Boya Li, Yanqing Wang
Summary: Alzheimer's disease (AD) is a globally prevalent neurodegenerative disorder, and the potential link between gut microbes and AD has attracted significant interest. This study used bibliometric analysis to investigate this field and found a consistent growth of research interest, with China making a prominent contribution. The study identified key research trends and themes, highlighting potential research gaps and providing valuable perspectives for future investigations.
Review
Immunology
Lynn van Olst, Sigrid J. M. Roks, Alwin Kamermans, Barbara J. H. Verhaar, Anne M. van der Geest, Majon Muller, Wiesje M. van der Flier, Helga E. de Vries
Summary: This review discusses the role of gut microbiota and their metabolites in influencing immunological changes in Alzheimer's disease. It highlights the potential of targeting gut microbiota to modulate inflammation as a promising future strategy in combating the progression of AD.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Gastroenterology & Hepatology
Xiaohang Qian, Wangxi Hai, Siyue Chen, Miao Zhang, Xufeng Jiang, Huidong Tang
Summary: This study investigated the potential mechanisms of gut microbiota in Alzheimer's disease (AD) by integrating multi-omics data. The results showed significant changes in the abundance of gut microbiota and levels of neuroinflammation in AD mice. Glycerophospholipid metabolism was found to be a common alteration pathway in AD mice. Integration analysis and fecal microbiota transplantation revealed the potential association of gut microbiota, host metabolism, and neuroinflammation in AD mice.
Article
Nutrition & Dietetics
Zhongbao Zhang, Xiaoqin Tan, Xiaorong Sun, Jianhua Wei, Qing X. Li, Zhongyi Wu
Summary: This study found that isoorientin can reduce AD-related markers by modulating the oral and gut microbiota. High-dose isoorientin treatment decreased amyloid beta 42 deposition in the brain, reduced the expression of inflammatory markers, and increased the levels of anti-inflammatory factors.
JOURNAL OF NUTRITION
(2022)
Article
Agriculture, Multidisciplinary
Shujian Wu, Zhenjun Zhu, Mengfei Chen, Aohuan Huang, Yizhen Xie, Huiping Hu, Jumei Zhang, Qingping Wu, Juan Wang, Yu Ding
Summary: Selenopeptide Val-Pro-Arg-Lys-Leu-SeMet (Se-P1) demonstrates superior antioxidant and antineuroinflammatory effects compared to its native peptide Val-Pro-Arg-Lys-Leu-Met (P1). Se-P1 treatment also results in a more stable gut microbiota composition and a significant correlation with the alteration of metabolites. These findings have implications for the development of preventive or therapeutic strategies against neurodegenerative diseases and provide insights into selenopeptide nutrition and supplementation recommendations.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2023)
Article
Biochemistry & Molecular Biology
Ran Wei, Zhucheng Su, Gerardo G. Mackenzie
Summary: This study evaluated the gut protecting effect of CGA and EGCG, major constituents of coffee and green tea, on d-galactose-induced aging mice. CGA plus EGCG improved cognition deficits and protected gut barrier function more effectively compared to the agents alone. Additionally, CGA and EGCG modulated the gut microbiome and reduced gut inflammation.
Article
Biochemistry & Molecular Biology
Omayma A. R. Abozaid, Mohsen W. Sallam, Sawsan El-Sonbaty, Samy Aziza, Basma Emad, Esraa S. A. Ahmed
Summary: The study found that resveratrol-selenium nanoparticles (RSV-SeNPs) can improve oxidative stress and inflammation, alleviate neurochemical deficits and promote neurite outgrowth in an Alzheimer's disease model.
BIOLOGICAL TRACE ELEMENT RESEARCH
(2022)
Article
Nanoscience & Nanotechnology
Licong Yang, Yanan Cui, Hanji Liang, Zhiwei Li, Na Wang, Yabin Wang, Guodong Zheng
Summary: Neuroinflammation in Alzheimer's disease can be effectively treated using selenium nanoparticles with different surface modifications. Specifically, Tg-CS/DMY@SeNPs, which are decorated with the blood brain barrier targeting peptide Tg, show improved anti-inflammatory effects and can cross the blood brain barrier to inhibit A beta aggregation. Furthermore, both Tg-CS/DMY@SeNPs and CS/DMY@SeNPs can repair the gut barrier and regulate the population of inflammatory-related gut microbiota.
ACS APPLIED MATERIALS & INTERFACES
(2022)
Article
Agriculture, Multidisciplinary
Zhiwei Li, Guodong Zheng, Na Wang, Hanji Liang, Changjiang Li, Yabin Wang, Yanan Cui, Licong Yang
Summary: Beta aggregation-related neuroinflammation and brain glucose homeostasis imbalance are important factors in Alzheimer's disease. Chlorogenic acid (CGA) is a common dietary polyphenol with neuroprotective effects, however, its bioavailability is low. This study developed a new flowerlike selenium nanocluster (TGN-CGA@SeNCs) to enhance the bioavailability of CGA.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2023)
Article
Agriculture, Multidisciplinary
Zhiwei Li, Guodong Zheng, Na Wang, Hanji Liang, Changjiang Li, Yabin Wang, Yanan Cui, Licong Yang
Summary: Beta aggregation-related neuroinflammation and brain glucose homeostasis imbalance are important in Alzheimer's disease (AD). Chlorogenic acid (CGA) has neuroprotective effects, but its low bioavailability necessitates high in vivo application doses. To enhance CGA bioavailability, a brain-targeting peptide (TGN peptide) and CGA were used to prepare a new flowerlike selenium nanocluster (TGN-CGA@SeNCs). TGN-CGA@SeNCs significantly improved CGA solubility, stability, and function in ameliorating gut microbiota disorder, A beta aggregation, and brain glucose homeostasis, providing potential for preventing AD progression.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2023)